Cargando…
A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
BACKGROUND/AIMS: Efficacy of proton pump inhibitors is limited in patients with nonerosive reflux disease (NERD). The aim of this study was to comparatively evaluate the efficacy and safety of esomeprazole with sodium bicarbonate and esomeprazole alone. METHODS: This was a multicenter, randomized, d...
Autores principales: | Park, Su Hyun, Lee, Kang Nyeong, Lee, Oh Young, Choi, Myung Gyu, Kim, Jie-Hyun, Sung, In-Kyung, Jang, Jae Young, Park, Kyung Sik, Chun, Hoon Jai, Kim, Eun Young, Lee, Jun Kyu, Jang, Jin Seok, Kim, Gwang Ha, Hong, Su Jin, Lee, Yong Chan, Choi, Suck-Chei, Kim, Hyun Soo, Kim, Tae Oh, Baik, Gwang Ho, Jeon, Yong Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018305/ https://www.ncbi.nlm.nih.gov/pubmed/35730245 http://dx.doi.org/10.5009/gnl220023 |
Ejemplares similares
-
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022) -
Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
por: Lee, Kwang Jae, et al.
Publicado: (2019) -
The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
por: Kim, Dasohm, et al.
Publicado: (2019) -
Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease
por: Jeon, Hye Kyung, et al.
Publicado: (2022) -
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
por: Lee, Ju Yup, et al.
Publicado: (2016)